• Issues related to opioid addiction recovery and drug treatment programs including S. 644 and H.R.1359, Modernizing Opioid Treatment Access Act; HR 2804 Harm Reduction Through Community Engagement Act of 2023 and HR 4531, Support for Patients and Communities Act.

Duration: June 27, 2017 to present

General Issues: Health Issues

Spending: about $390,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2017: House of Representatives, U.S. Senate, Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office, Office of Natl Drug Control Policy (NDCP), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)